Recurrent Malignant Bowel Obstruction: Surgery, Venting Gastrostomy, or Comfort Care?
A 67-year-old woman with recurrent ovarian cancer, peritoneal carcinomatosis, and a second malignant bowel obstruction in six weeks has nausea, vomiting, colicky abdominal pain, and no flatus for three days. CT shows multiple transition points, ascites, and tumor encasing the mesentery; there is no single surgical target. She has ECOG performance status 2, albumin 2.4, and creatinine 1.4. She previously had surgery for obstruction and says, 'I can't keep doing this.' She asks whether a 'stomach tube' would help and whether she can go home.
1. What is your differential for her symptoms, and what determines whether surgical or medical management is appropriate? How would you use prognostic and outcome data without over-relying on a single score?
Read the worked answer
The first question is whether the obstruction is mechanical and surgically correctable or functional and multifactorial. Multiple transition points, ascites, mesenteric tumor encasement, prior surgery, low albumin, and ECOG 2 all argue against a good surgical outcome. The differential includes mechanical obstruction from tumor, adhesions, or hernia; functional obstruction from carcinomatosis or opioid-induced dysmotility; constipation; and ascites causing bowel compression. A single transition point with a good performance status and no ascites would favor surgery; this pattern does not. Scores such as the Glasgow Obstruction Score or the Palliative Prognostic Index can inform but should not dictate care, because they were derived in specific populations and do not capture her values. I would ask what she means by 'I can't keep doing this'-is it the vomiting, the hospital, or the cancer trajectory? If she wants to go home, a venting gastrostomy or octreotide may make that possible; if she is dying, comfort-focused medical management is appropriate. The decision is not 'operate or do nothing'; it is which intervention best matches her goals and likely benefit.
2. Outline a medication regimen for nausea, colic, and vomiting, including routes and sequencing, and explain why some standard antiemetics may worsen colic.
Read the worked answer
Start with octreotide 100–300 mcg subcutaneously every 8 hours (or a continuous infusion), which reduces gastrointestinal secretions and vomiting; it is often combined with dexamethasone 4–8 mg daily to reduce tumor edema and inflammation. For nausea, haloperidol 0.5–1 mg SC or IV every 6–8 hours or ondansetron 4–8 mg IV every 8 hours are reasonable. Metoclopramide is a prokinetic and can help if there is no colic, but it can worsen cramping and should be avoided when there is high-grade mechanical obstruction or colic. For colicky pain, anticholinergics such as hyoscyamine or glycopyrrolate may reduce spasms, and opioids treat pain. Scopolamine can help secretions but may cause delirium. An NG tube can decompress the stomach temporarily and relieve vomiting, but it is uncomfortable and not a long-term home solution; a venting gastrostomy is better for recurrent obstruction in a patient who wants to be home. Subcutaneous fluids may relieve thirst and dehydration symptoms if consistent with goals, but they can increase secretions and vomiting. The regimen should be sequenced: decompress if needed, reduce secretions, control pain and nausea, then reassess within 24–48 hours.
3. She asks about 'the tube' and says she doesn't want to be a burden. How do you discuss venting gastrostomy versus NG tube versus hospice, and what would you document?
Read the worked answer
I would clarify what she means by 'the tube' and what she fears about being a burden. Explain that a nasogastric tube goes through the nose and is temporary, usually used in hospital; a venting gastrostomy is placed through the abdominal wall and lets the stomach drain continuously, which can relieve vomiting and allow her to be home. It does not provide nutrition, and it does not treat the cancer. A venting gastrostomy is a comfort intervention, but it requires a procedure and can have complications. If she is actively dying or does not want procedures, medical management alone with octreotide and dexamethasone may be enough. I would ask: 'What would make the next weeks worthwhile for you? Is being home more important than avoiding a procedure?' Then document her goals, her understanding of the options, her surrogate, code status, and the plan for a time-limited trial. If she chooses home, involve home hospice and arrange supplies and after-hours support. If she chooses the venting gastrostomy, document that it is for symptom control, not nutrition, and set clear criteria for when to stop.